BBE-like Oxidase Microbial Cannabinoid Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current synthetic approaches for carbon(sp3)-hydrogen (C—H) bond functionalization, particularly for benzylic positions, face challenges due to high bond dissociation energy, poor regioselective and stereoselective control, and potential over-oxidation, with limitations in scalability due to enzyme stability and expression levels from plant or fungal sources.
Innovation Solution
The use of berberine bridge enzyme (BBE)-like oxidases, such as Tcz9 and Clz9, which catalyze benzylic hydroxylation and cycloaddition reactions, enabling the production of cannabinoids through microbial systems, thereby overcoming traditional synthetic limitations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If plant or fungal enzymes are used for benzylic C-H functionalization, then the reaction can proceed under milder conditions, but scalability is limited due to reduced protein expression levels and stability
Solution Approach 1:
The invention changes the source organism parameter from plant/fungal to bacterial (Streptomyces, Actinomycete), which fundamentally alters the enzyme's expression characteristics and stability profile. Bacterial BBE-like oxidases exhibit enhanced stability and expression levels in microbial hosts, directly resolving the scalability limitation while maintaining catalytic functionality for benzylic C-H functionalization
2Ease of manufacture
If traditional synthetic approaches are used for C-H bond functionalization, then the methodology is well-established, but the process requires toxic reagents and harsh reaction conditions
Solution Approach 1:
The invention replaces traditional chemical synthesis mechanisms (using toxic reagents and harsh conditions) with a biocatalytic mechanism. BBE-like oxidases catalyze benzylic C-H functionalization under mild physiological conditions, eliminating the need for toxic reagents while maintaining manufacturing feasibility through enzyme-based catalysis
3Manufacturing precision
If conventional biocatalytic methods are used, then selectivity can be achieved, but enzyme expression levels and stability from plant or fungal sources limit scalability
Solution Approach 1:
The invention changes the biological source parameter from plant/fungal to bacterial, which resolves the contradiction by providing enzymes with both high selectivity and improved expression characteristics. Bacterial BBE-like oxidases maintain the regioselective and stereoselective capabilities while exhibiting superior expression levels and stability in microbial production systems
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for the efficient and selective functionalization of benzylic C—H bonds, achieving high yields of cannabinoids like cannabichromenic acid (CBCA) in a bacterial system, demonstrating improved regioselectivity, stereoselectivity, and scalability compared to traditional methods.
Implementation Method 1
berberine bridge enzyme (BBE)-like oxidases, such as Tcz9 and Clz9, which catalyze benzylic hydroxylation and cycloaddition reactions
Implementation Method 2
BBE-like oxidases that catalyze reactions including benzylic hydroxylation
Data Source
AI summary
The disclosure relates to a method of making at least one cannabinoid comprising contacting at least one berberine bridge enzyme like (BBE-like) oxidase with at least one substrate, wherein the substrate comprises a cannabinoid precursor. The cannabinoid precursor can include cannabigerolic acid dihydrotetrachlorizine, prechlorizidine, cannabigerorcinic acid, grifolic acid, or a combination thereof.